Antisense modulation of CD44 expression

Details Antisense modulation of CD44 expression Antisense modulation of CD44 expression

1998-12-17

2000-11-21

Elliot, George C.

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

435 6, 435 911, 435366, 435375, 435455, 536 231, 536 245, 536 253, C12Q 168, C12P 1334, C07H 2102, C07H 2104, C07H 2100

Patent

active

06150162&

ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of CD44. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding CD44. Methods of using these compounds for modulation of CD44 expression and for treatment of diseases associated with expression of CD44 are provided.

REFERENCES:
patent: 5506126 (1996-04-01), Seed et al.
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5990299 (1999-11-01), Ruzdijic et al.
Harn, H-J. et al. 1991 Biochem Biophys Res. Comm. vol. 178(3): pp. 1127-1134.
Merzak, A. et al 1994. Cancer Res. vol 54: pp. 3988-3992.
Crooke, St. 1998 Antisense Res & Appli. Ch. 1, pp. 1-50, Pub: Springer.
Branch, A. 1998 Trends in Bioch. Sci. (TIBS) vol. 23, pp. 45-50.
James, W. 1991 Antivir. Chem. & Chemo-Ther. vol. 2(4), pp. 191-214.
Milner, N et al 1997 Nature Biotech vol. 15, pp. 537-541.
Chow et al., Antisense inhibition of chondrocyte CD44 expression leading to cartilage chondrolysis, Arthritis Rheum, 1998, 41:1411-1419.
Cooper, Retention of CD44 introns in bladder cancer: understanding the alternative splicing of pre-mRNA opens new insights into the pathogenesis of human cancer, J. Pathol., 1995, 177:1-3.
Gunthert et al., A new variant of glycoprotein CD44 confers metastatic potential to rat cacinoma cells, Cell, 1991, 65:13-24.
Kaya et al., Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation, Genes Dev, 1997, 11:996-1007.
Lamb et al., AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44, Mol Cell Biol, 1997, 17:963-976.
Merzak et al., CD44 mediates human glioma cell adhesion and invasion in vitro, Cancer Res, 1994 54:3988-3992.
Naor et al., CD44: structure, function, and association with the malignant process, Adv. Cancer Res., 1997, 71:241-319.
Reeder et al., Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment, Cancer Res, 1998, 58:3719-3726.
Stamenkovic et al., The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells, Embo J, 1991, 10:343-348.
Tarin et al., The clinical significance of malfunction of the CD44 locus in malignancy, J. Neuroonocol., 1995, 26:209-219.
Zhu et al., 1996 in Targeting of Drugs 5: Strategies for oligonucleotide and gene delivery in therapy. (G. Gregoriadis and B. McCormack, Eds.) pp. 169-178, Plenum Press, New York.

Affiliated with

Also associated with

Rating

Antisense modulation of CD44 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of CD44 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of CD44 expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1255619